BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9310121)

  • 1. Inhibition of superoxide production and chemotaxis by methotrexate in neutrophils primed by TNF-alpha or LPS.
    Okuda A; Kubota M; Watanabe K; Sawada M; Koishi S; Kataoka A; Usami I; Lin YW; Furusho K
    Eur J Haematol; 1997 Sep; 59(3):142-7. PubMed ID: 9310121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methotrexate inhibits superoxide production and chemotaxis in neutrophils activated by granulocyte colony-stimulating factor.
    Okuda A; Kubota M; Sawada M; Koishi S; Kataoka A; Bessho R; Usami I; Lin YW; Adachi S; Furusho K
    J Cell Physiol; 1996 Jul; 168(1):183-7. PubMed ID: 8647914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The protein kinase C inhibitor AEB071 (sotrastaurin) modulates migration and superoxide anion production by human neutrophils in vitro.
    Capsoni F; Ongari AM; Reali E; Bosè F; Altomare GF
    Int J Immunopathol Pharmacol; 2012; 25(3):617-26. PubMed ID: 23058012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of human neutrophil and monocyte chemotaxis and superoxide responses by recombinant TNF-alpha and GM-CSF.
    Kharazmi A; Nielsen H; Bendtzen K
    Immunobiology; 1988 Sep; 177(4-5):363-70. PubMed ID: 2848761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of TNF-alpha-priming and stimulation-dependent superoxide generation in human neutrophils by protein kinase inhibitors.
    Utsumi T; Klostergaard J; Akimaru K; Edashige K; Sato EF; Utsumi K
    Arch Biochem Biophys; 1992 Apr; 294(1):271-8. PubMed ID: 1312809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-8 priming of human neutrophils is not associated with persistently altered calcium fluxes but is additive with lipopolysaccharide.
    Van Dervort AL; Lam C; Culpepper S; Tuschil AF; Wesley RA; Danner RL
    J Leukoc Biol; 1998 Oct; 64(4):511-8. PubMed ID: 9766632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual effects of formylpeptides on the adhesion of endotoxin-primed human neutrophils.
    Bellavite P; Chirumbolo S; Lippi G; Andrioli G; Bonazzi L; Ferro I
    Cell Biochem Funct; 1993 Dec; 11(4):231-9. PubMed ID: 7903912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Priming of human neutrophil functions by tumor necrosis factor: enhancement of superoxide anion generation, degranulation, and chemotaxis to chemoattractants C5a and F-Met-Leu-Phe.
    Bajaj MS; Kew RR; Webster RO; Hyers TM
    Inflammation; 1992 Jun; 16(3):241-50. PubMed ID: 1323530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p38 mitogen-activated protein kinase activation is required for human neutrophil function triggered by TNF-alpha or FMLP stimulation.
    Zu YL; Qi J; Gilchrist A; Fernandez GA; Vazquez-Abad D; Kreutzer DL; Huang CK; Sha'afi RI
    J Immunol; 1998 Feb; 160(4):1982-9. PubMed ID: 9469462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Priming induces functional coupling of N-formyl-methionyl-leucyl-phenylalanine receptors in equine neutrophils.
    Brazil TJ; Rossi AG; Haslett C; McGorum B; Dixon PM; Chilvers ER
    J Leukoc Biol; 1998 Mar; 63(3):380-8. PubMed ID: 9500527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of tumor necrosis factor-alpha on the stimulus-coupled responses of neutrophils and their modulation by various inhibitors.
    Utsumi T; Klostergaard J; Akimaru K; Sato EF; Yoshioka T; Utsumi K
    Physiol Chem Phys Med NMR; 1992; 24(2):77-88. PubMed ID: 1324505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine modulation of tumor necrosis factor-alpha-induced neutrophil activation.
    Barnes CR; Mandell GL; Carper HT; Luong S; Sullivan GW
    Biochem Pharmacol; 1995 Nov; 50(11):1851-7. PubMed ID: 8615864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective inhibition of human TNF-alpha action by flecainide acetate, an antiarrhythmic drug.
    Nojima S; Kobuchi H; Saibara T; Yasuda T; Utsumi K
    Physiol Chem Phys Med NMR; 1995; 27(2):77-89. PubMed ID: 7568419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Priming of neutrophils by lipopolysaccharide for enhanced release of superoxide. Requirement for plasma but not for tumor necrosis factor-alpha.
    Aida Y; Pabst MJ
    J Immunol; 1990 Nov; 145(9):3017-25. PubMed ID: 2170529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antifolate 10-deazaaminopterin inhibits neutrophil chemotaxis and superoxide generation.
    Weber GF; Nair MG; McCord JM
    Immunopharmacol Immunotoxicol; 1991; 13(3):379-93. PubMed ID: 1658111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anthrax toxin blocks priming of neutrophils by lipopolysaccharide and by muramyl dipeptide.
    Wright GG; Mandell GL
    J Exp Med; 1986 Nov; 164(5):1700-9. PubMed ID: 3021891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normal oxidative activity and chemotaxis of circulating neutrophils in patients treated with photopheresis.
    Obel N; Storgaard M; Hansen B; Zachariae H
    Arch Dermatol Res; 1994; 286(1):18-20. PubMed ID: 8141608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An inhibitor of ornithine decarboxylase antagonizes superoxide generation by primed human polymorphonuclear leukocytes.
    Walters JD; Cario AC; Danne MM; Marucha PT
    J Inflamm; 1998; 48(1):40-6. PubMed ID: 9368191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of chemotactic peptide-induced activation of phosphoinositide 3-kinase by granulocyte-macrophage colony-stimulating factor and its relation to the cytokine-mediated priming of neutrophil superoxide-anion production.
    Kodama T; Hazeki K; Hazeki O; Okada T; Ui M
    Biochem J; 1999 Jan; 337 ( Pt 2)(Pt 2):201-9. PubMed ID: 9882616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of rat neutrophil functions by administration of granulocyte colony-stimulating factor.
    Murata K; Watanabe T; Yamashita T; Gon S; Sendo F
    J Leukoc Biol; 1995 Feb; 57(2):250-6. PubMed ID: 7531746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.